IRIS
DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.616
EU - Europa 6.352
AS - Asia 5.535
SA - Sud America 618
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 21.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.470
SG - Singapore 2.162
CN - Cina 1.867
IT - Italia 1.227
IE - Irlanda 994
UA - Ucraina 992
GB - Regno Unito 848
SE - Svezia 717
TR - Turchia 709
BR - Brasile 517
FR - Francia 485
DE - Germania 434
IN - India 269
FI - Finlandia 210
VN - Vietnam 206
RU - Federazione Russa 187
CA - Canada 81
HK - Hong Kong 57
JP - Giappone 50
MX - Messico 49
PL - Polonia 47
BD - Bangladesh 45
ES - Italia 44
AT - Austria 38
AR - Argentina 37
ZA - Sudafrica 32
KR - Corea 30
NL - Olanda 28
IQ - Iraq 26
CZ - Repubblica Ceca 22
EC - Ecuador 20
BE - Belgio 18
CH - Svizzera 17
ID - Indonesia 13
LT - Lituania 13
EU - Europa 11
IL - Israele 11
IR - Iran 11
MA - Marocco 10
SA - Arabia Saudita 10
VE - Venezuela 10
CO - Colombia 9
LB - Libano 9
KE - Kenya 8
PK - Pakistan 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
MY - Malesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
AU - Australia 6
EG - Egitto 6
CL - Cile 5
PE - Perù 5
GR - Grecia 4
JO - Giordania 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
BY - Bielorussia 3
DK - Danimarca 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
RO - Romania 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NR - Nauru 1
PR - Porto Rico 1
SI - Slovenia 1
Totale 21.208
Salva come PNG Salva come JPEG
Città #
Singapore 1.564
Chandler 1.323
Jacksonville 1.199
Dublin 990
Dearborn 642
Southend 574
Dallas 526
Beijing 486
Princeton 475
Ashburn 436
Izmir 376
Nanjing 342
Los Angeles 208
Chieti 200
Wilmington 184
Cambridge 182
Santa Clara 171
Tongling 151
The Dalles 131
Nanchang 125
Altamura 120
Ann Arbor 113
Buffalo 113
New York 100
Boardman 90
Munich 87
Ho Chi Minh City 72
Kunming 70
Rome 69
Pescara 61
Shenyang 60
São Paulo 60
Hebei 59
Redondo Beach 58
Hong Kong 56
Dong Ket 49
Jiaxing 45
Washington 42
Woodbridge 41
Moscow 40
Tianjin 40
Hefei 37
Norwalk 36
Warsaw 36
Tokyo 35
Milan 34
Brooklyn 32
Vienna 32
Chicago 31
Changsha 27
Houston 27
Montreal 27
Boston 26
Council Bluffs 26
Stockholm 26
Pune 24
Hangzhou 23
Atlanta 22
Hanoi 22
Johannesburg 22
Phoenix 22
Nuremberg 21
Seoul 21
Chennai 20
Grevenbroich 20
Jinan 20
Seattle 20
Augusta 19
San Mateo 19
Toronto 19
Poplar 18
Amsterdam 17
Brussels 17
Frankfurt am Main 17
Orange 17
Orem 17
Zhengzhou 17
Düsseldorf 16
Ancona 15
Ankara 15
Denver 15
Guangzhou 15
Helsinki 15
Rio de Janeiro 15
San Francisco 15
Turku 15
Brno 14
Kocaeli 14
London 14
Mexico City 14
Palermo 14
Civitanova Marche 13
Lanzhou 13
Mumbai 13
Auburn Hills 12
Falls Church 12
Teramo 12
Vittuone 12
Changchun 11
Quito 11
Totale 12.911
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 208
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 178
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 174
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 170
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 160
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 156
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 151
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 141
Colonic adenoma-associated Escherichia coli express specific phenotypes 135
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 131
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 130
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 129
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 127
null 125
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 124
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 124
In vitro microbiology studies on a new peritoneal dialysis connector 120
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 119
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 118
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 118
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 117
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 116
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 116
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 116
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 116
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 115
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 115
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 115
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 115
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 114
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 113
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 113
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 112
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 112
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 112
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 110
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 109
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 108
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 108
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 107
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 107
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 107
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 107
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 106
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 106
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 106
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 105
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 105
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 105
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 105
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 104
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 104
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 104
Normal breathing releases SARS-CoV-2 into the air 104
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 103
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 103
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 102
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 102
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 102
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 102
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 101
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 101
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 101
Attività in vitro di roxitromicina in confronto con eritromicina verso Actinobacillus actinomycetemcomitans. 101
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 101
Hafnia alvei from the farm to the delivery room 101
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 100
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 100
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 100
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 100
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 99
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 99
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 99
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 99
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 99
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 98
Salmonella typhimurium-endocarditis secondary to an acquired environmental infection: a case report. 98
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 98
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 97
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 97
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 97
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 97
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 97
Influenza di fattori abiotici sulla produzione di biofilm da parte di Stenotrophomonas maltophilia. 96
Attività in vitro di fluorochinoloni nei confronti del biofilm prodotto da Stenotrophomonas maltophilia. 96
Caratterizzazione fenotipica e genotipica della formazione di biofilm da parte di Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 96
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 96
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. 95
Virulence factors of Stenotrophomonas maltophilia, an emergent pathogen associated to cystic fibrosis. 95
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 95
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 95
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 95
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 95
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 95
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 95
Effetto dello swimming e della idrofobicità superficiale di Stenotrophomonas maltophilia sull’adesività e sulla formazione di biofilm su polistirene. 94
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach. 94
Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. 94
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 94
Valutazione dell’espressione delle oncoproteine di Papillomavirus nella gestione e nel triage delle donne in follow-up per lesioni di basso grado. 94
Totale 11.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.021
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021807 0 0 0 0 0 266 20 33 116 212 53 107
2021/20221.270 40 47 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.743 248 614 464 115 88 146 136 159 472 184 441 676
2025/20263.636 590 344 874 885 857 86 0 0 0 0 0 0
Totale 22.197